We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Moleculin Biotech Inc | TG:MOL | Tradegate | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.00 | - |
From Jul 2019 to Jul 2024
BUDAPEST--Hungarian oil company MOL Nyrt. (MOL.BU) announced Thursday a deal to buy a 49% share in JSC Karpovskiy Severniy, the holder of the North Karpovsky exploration license in Kazakhstan, a subsidiary of JSC Kazmunaigas Exploration and Production (RDGZ.KX), owned by Kazakh state oil company JSC Kazmunaigas.
MAIN FACTS:
- MOL Announces Deal to Buy 49% in Kazakh JSC Karpovskiy Severniy
- JSC Karpovskiy Severniy is owned by JSC Kazmunaigas Exploration and Production
- North Karpovsky block located in the vicinity of MOL's Fedorovsky block
- MOL has 27.5% share in Fedorovsky block
- Total prospective recoverable resources are 240 million BOE, according to KMG EP estimates
- Area well covered by seismic data, information from exploration wells, MOL says
- Transaction subject to consent of Kazakh ministry, and EU, local antimonopoly bodies
- MOL closed up 0.6% at HUF16,800 Wednesday.
Write to the Budapest Bureau at budapest@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Moleculin Biotech Chart |
1 Month Moleculin Biotech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
